PLoS Neglected Tropical Diseases, 2021 Single brain enhancing lesions (SEL) are the most common presentation of neurocysticercosis (NCC) observed on neuroimaging in people presenting with epileptic seizures not only on the Indian sub-continent and in travelers returning from cysticercosis ...
Annette Abraham +16 more
doaj +2 more sources
The influence of demographics and comorbidity on persistence with anti-seizure medication [PDF]
Seizure, 2022 To examine the rate of persistence with anti-seizure medications (ASMs) in a cohort of patients with epilepsy, and to investigate the impact of a range of clinical and demographic factors on persistence METHODS: Patients receiving ASMs for epilepsy were identified from linked, routinely collected data within the NHS Greater Glasgow and Clyde health ...
Marshall, A.D. +4 more
openaire +3 more sources
Frontiers in Pharmacology, 2022 Aim: To provide a comparison of genotyping for HLA risk alleles versus patch testing to determine which of these two tests is a better diagnostic tool for cutaneous hypersensitivity reactions caused by anti-seizure medication.Methods: A literature study ...
Lisanne E. N. Manson +4 more
doaj +3 more sources
Initial Monotherapy and Further Anti-seizure Medication Regimens in Adult Patients with Epilepsy: A Population-Based, Longitudinal, Retrospective Analysis of German Prescription Data [PDF]
Neurology and TherapyIntroduction In Germany, approximately 30% of people with epilepsy do not achieve seizure control with anti-seizure medication (ASM). ASM prescription timing and selection are crucial parameters affecting outcomes; however, the prescription ...
Adam Strzelczyk +3 more
doaj +2 more sources
Drosophila melanogaster as a rapid in vivo assay system for preclinical anti‐seizure medication testing [PDF]
Epilepsia OpenEpilepsy represents a significant medical challenge, with a third of patients failing to achieve seizure freedom despite the use of multiple different anti‐seizure medications (ASM). Drug resistance is common in genetically caused epilepsies.
Emma V. Töfflinger +4 more
doaj +2 more sources
Seizure control by adding on other anti-seizure medication on seizure during levetiracetam administration in patients with glioma-related epilepsy [PDF]
BMC Cancer, 2023 Background Epilepsy is a major symptom in patients with glioma. Levetiracetam (LEV) is recognized as a first-line treatment for glioma-related epilepsy.
Etsuko Yamamoto Hattori +8 more
doaj +2 more sources
Epilepsy & Behavior Reports, 2023 Objectives: We sought to determine risk factors associated with seizure recurrence following initial withdrawal of anti-seizure medications (ASM) among children with epilepsy. Methods: This was a retrospective observational study of children aged between
Nicholas Odero +3 more
doaj +3 more sources
Anti-seizure Medication Induced Cognitive Impairment in Children with Epilepsy: A Narrative Review. [PDF]
Iran J Child NeurolSeveral circumstances, including the etiology of epilepsy, its early onset, recurrent seizures, and the use of anti-seizure medications (ASMs), can lead to cognitive impairment in people with epilepsy.
Armide N, Babaei M.
europepmc +2 more sources
Discovery ofE2730, a novel selective uncompetitiveGAT1inhibitor, as a candidate for anti‐seizure medication [PDF]
Epilepsia Open, 2023 Fukushima K +14 more
exaly +2 more sources
Anti-seizure medication tapering correlates with daytime delta band power reduction in the cortex. [PDF]
Brain Commun\ua9 The Author(s) 2025. Published by Oxford University Press on behalf of the Guarantors of Brain. Anti-seizure medications are the primary treatment for epilepsy; yet medication tapering effects have not been investigated in a dose, region and time ...
Besné GM +13 more
europepmc +2 more sources